A scientist went viral for exposing a cancer drug cover-up — the pharmaceutical industry buried a treatment

The Cancer Drug They Buried

A scientist went viral on Instagram with a devastating claim: the pharmaceutical industry buried an effective cancer treatment because it wasn't profitable enough. The post was shared millions of times because it confirmed what cancer patients have long suspected — the industry profits from treatment, not cures.

The Business Model

Cancer treatment generates roughly $200 billion annually worldwide. A cure would destroy that market overnight. The pharmaceutical industry's fiduciary duty is to shareholders, not patients. From a pure business perspective, a treatment that requires years of ongoing purchases is infinitely more valuable than a cure that works once.

The Pattern

This isn't the first time. In the 1990s, the EPO drug scandal saw Johnson & Johnson push dangerous dosing of a cancer drug to maximize profits. STAT News documented how the scandal "explains RFK Jr.'s agenda" — the pattern of pharma putting profits over patients is so well-documented that it's now driving policy discussions.

The DOJ Connection

The DOJ recently sentenced the owners and CEO of a wholesale pharmaceutical company for distributing more than $92 million in black market drugs. When the system that's supposed to regulate pharma is processing billion-dollar fraud cases, the industry isn't being regulated — it's being managed.